Research programme: small molecule therapeutics - University of Texas M. D. Anderson Cancer Center/X-Chem
Latest Information Update: 08 Jan 2016
At a glance
- Originator University of Texas M. D. Anderson Cancer Center; X-Chem
- Class Antineoplastics; Small molecules
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer